{"prompt": "['GENITOURINARY', 'Grade 1', 'Grade 2', 'Grade 3', 'Grade 4', 'Intermenstrual Bleeding', 'Spotting observed by participant', 'Intermenstrual bleeding not', 'Intermenstrual bleeding greater', 'Hemorrhage with life-', '(IMB)', 'OR Minimal blood observed', 'greater in duration or amount', 'in duration or amount than usual', 'threatening hypotension OR', 'during clinical or colposcopic', 'than usual menstrual cycle', 'menstrual cycle', 'Operative intervention', 'exam', 'indicated', 'Urinary Tract', 'NA', 'Signs or symptoms of urinary', 'Signs or symptoms of urinary', 'Obstruction causing life-', 'obstruction (eg, stone)', 'tract obstruction without', 'tract obstruction with', 'threatening consequences', 'hydronephrosis or renal', 'hydronephrosis or renal', 'dysfunction', 'dysfunction', 'INFECTION', 'Grade 1', 'Grade 2', 'Grade 3', 'Grade 4', 'Infection (any other', 'Localized, no systemic antiubial', 'Systemic antiubial treatment', 'Systemic antiubial treatment', 'Life-threatening', 'than HIV infection)', 'treatment indicated AND', 'indicated OR Symptoms', 'indicated AND Symptoms', 'consequences (eg, septic', 'Symptoms causing no or', 'causing greater than minimal', 'causing inability to perform', 'shock)', 'minimal interference with usual', 'interference with usual social', 'usual social & functional', 'social & functional activities', '& functional activities', 'activities OR Operative', 'intervention (other than simple', 'incision and drainage) indicated', 'Basic Self-care Functions: Activities such as bathing, dressing, toileting, transfer/movement, continence, and feeding.', 'Usual Social & Functional Activities: Adaptive tasks and desirable activities, such as going to work, shopping, cooking, use of transportation, pursuing a hobby, etc.', 'CRI 15-05 Protocol 13SEP2017', 'Page 72']['Appendix 5:', 'Pregnancy Precautions, Definition for Female of Childbearing', 'Potential, and Contraceptive Recommendations', 'Pregnancy and Contraception Requirements for Males and Females of Childbearing', 'Potential', 'Non-clinical toxicity studies of Epclusa demonstrated no adverse effect on embryo-fetal development.', 'However, there are no clinical studies of Epclusa in pregnant women. Please refer to the latest version of', \"the Investigator's Brochure for additional information.\", 'Definition of Female of Childbearing Potential and Contraceptive Requirements for Female', 'Subjects (and their male partners)', 'Women >54 years of age with cessation for >12 months of previously occurring menses, or women of', 'any age who have had a hysterectomy, have had both ovaries removed, or have had medically', 'documented ovarian failure will be considered to be of non-childbearing potential.', 'Women who are VI 54 years of age (including those with amenorrhea of any duration) who have not had', 'a hysterectomy, have not had both ovaries removed, and have not had medically documented ovarian', 'failure will be considered to be of childbearing potential.', 'Women of childbearing potential must have a negative serum pregnancy test at screening and a', 'negative urine pregnancy test on the Baseline/Day 1 visit prior to enrollment. They must also agree to', 'one of the following from 3 weeks prior to Baseline/Day 1 until 30 days after last dose of study drug:', '1) Complete abstinence from intercourse. Periodic abstinence (e.g., calendar, ovulation,', 'symptothermal, post-ovulation methods) is not permitted.', 'Or', '2) Consistent and correct use of 1 of the following methods of birth control listed below in', 'addition to a male partner who correctly uses a condom from the date of screening until 30', 'days after last dose of study drug:', 'a) intrauterine device (IUD) with a failure rate of < 1% per year', 'b)', 'female barrier method: cervical cap or diaphragm with spermicidal agent (if locally', 'available)', 'c) tubal sterilization', '3) vasectomy in male partner', 'a) hormone-containing contraceptive:', 'i) implants of levonorgestrel', 'ii) injectable progesterone', 'iii) oral contraceptives (either combined or progesterone only)', 'iv) contraceptive vaginal ring', 'v) transdermal contraceptive patch', '3. Contraceptive Requirements for Male Subjects (and their female partners)', 'All male study participants must agree to consistently and correctly use a condom, while their female', 'partner agrees to use 1 of the methods of birth control listed above, from the date of screening until 90', 'CRI 15-05 Protocol 13SEP2017', 'Page 73']\n\n###\n\n", "completion": "END"}